Sustained Release Heterodisperse Hydrogel Systems - Amorphous Drugs

Details for Australian Patent Application No. 2004201845 (hide)

Owner Penwest Pharmaceuticals Co.

Inventors Baichwal, Anand R

Agent Wrays

Pub. Number AU-B-2004201845

Parent 770001

Filing date 4 May 2004

Wipo publication date 27 May 2004

Acceptance publication date 8 February 2007

International Classifications

A61K 9/22 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

Event Publications

20 May 2004 Complete Application Filed

27 May 2004 Application Open to Public Inspection

  Published as AU-B-2004201845

10 November 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

23 February 2006 Section 223 Application Received

  Penwest Pharmaceuticals Co. An application to extend the time from 18 Apr 2005 to 18 Jan 2006 in which to pay a continuation fee has been filed . Address for service in Australia - Wray & Associates Level 4, The Quadrant 1 Williams Street Perth WA 6000 Extensions of Time, Section 223

13 April 2006 Section 223 Application Allowed

  Penwest Pharmaceuticals Co. The time in which to pay a continuation fee has been extended to 18 Jan 2006. Address for service in Australia - Wray & Associates Level 4, The Quadrant 1 Williams Street Perth WA 6000

8 February 2007 Application Accepted

  Published as AU-B-2004201845

29 November 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

2 October 2008 Section 223 Application Received

  Penwest Pharmaceuticals Co. An application to extend the time from 18 Apr 2007 to 18 Apr 2008 in which to pay a continuation fee has been filed . Address for service in Australia - Wrays Ground Floor 56 Ord Street West Perth WA 6005

20 November 2008 Section 223 Application Allowed

  Penwest Pharmaceuticals Co. The time in which to pay a continuation fee has been extended to 18 Apr 2008. Address for service in Australia - Wrays Ground Floor 56 Ord Street West Perth WA 6005 Extensions of Time, Section 223 2008

27 November 2008 Standard Patent Sealed

12 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004201846-Membrane filter with deaeration and method for the manufacture thereof

2004201844-Joint orthosis